Low libido in women is far more common than many people realise, affecting up to 40% of women at some point in their lives. The causes of low libido in women range from hormonal imbalances and menopause to stress, relationship issues, and medications. Understanding low libido in women requires looking at the full picture — physical health, mental wellbeing, and relationship dynamics all play a role. Many women with low libido in women feel isolated, but effective treatments exist for every underlying cause. This comprehensive guide explores everything you need to know about low libido in women and the proven strategies that work.
Low libido in women is one of the most common sexual health concerns, affecting up to 40% of women at some point in their lives. Low libido in women can stem from hormonal imbalances, relationship issues, stress, medication side effects, or underlying health conditions. Understanding the root cause of low libido in women is critical because treatment approaches differ significantly depending on the cause. This evidence-based guide covers the proven causes, hormonal factors, and most effective solutions for low libido in women.
Table of Contents
There’s a phrase that gets used a lot when women talk about low libido: “I’m just not in the mood.” It’s casual, it’s normalizing, and it misses something important — what’s driving that absence of mood? Low sexual desire in women, formally called Hypoactive Sexual Desire Disorder (HSDD) when it causes distress, affects approximately 43% of women at some point in their lives. It is the most common female sexual complaint worldwide. And yet, it remains dramatically undertreated.
This isn’t about wanting sex as often as your partner. It’s not about having a “high” versus “low” libido personality. HSDD is defined as persistently reduced or absent desire for sexual activity that causes personal distress. The distress part matters — low libido that doesn’t bother you isn’t a disorder. But when it affects your relationship, your sense of self, or your quality of life, it deserves attention.
Low Libido in Women: Key Causes and Evidence-Based Solutions
What Actually Controls Female Sexual Desire?
Women’s sexuality is more complex than a simple “on/off” switch. Research by Rosemary Basson introduced a non-linear model of female sexual response — where desire often emerges during intimacy rather than before it, particularly in long-term relationships. This is fundamentally different from the traditional (male-centric) linear model and explains why many women in committed relationships experience responsive rather than spontaneous desire — a normal variant, not a disorder.
That said, when desire is absent even in the right context — when a woman doesn’t feel aroused even with appropriate stimulation, emotional connection, and absence of distraction — something physiological or psychological is interfering. Here’s what the research says actually drives female libido:
- Testosterone (yes, women have it too): Women produce testosterone in the ovaries and adrenal glands. Though present in smaller amounts than in men, it plays a critical role in sexual desire, arousal, and orgasm. Low free testosterone is one of the most common hormonal drivers of HSDD.
- Estrogen: Critical for vaginal lubrication, clitoral sensitivity, and overall sexual comfort. When Estrogen drops (menopause, post-partum, long-term hormonal contraceptive use), libido often drops with it.
- Dopamine and Serotonin: The brain’s reward circuits drive sexual motivation. SSRIs (selective serotonin reuptake inhibitors) block dopamine signaling — which is exactly why antidepressants are one of the most common causes of iatrogenic (medication-caused) low libido.
- Cortisol: The stress hormone directly suppresses testosterone and estrogen production. High chronic stress = biochemically suppressed libido, independent of psychological factors.
The Hormone That Nobody Talks About in Women: Testosterone
If you’ve ever been told “women don’t need testosterone” — that advice is outdated. The Endocrine Society’s 2019 Clinical Practice Guidelines explicitly recommend testosterone therapy for postmenopausal women with HSDD, citing strong evidence from multiple randomized controlled trials.
A 2019 systematic review in The Lancet Diabetes & Endocrinology (analyzing 36 RCTs, 8,480 participants) found that testosterone therapy significantly improved:
- Sexual desire/libido scores
- Arousal and orgasm frequency
- Satisfying sexual event frequency
- Sexual self-image and responsiveness
The key word is low-dose. Testosterone therapy for women uses doses much smaller than those used in men — typically topical gels or creams in the 1-2% concentration range, applied to the skin. At these doses, masculinizing side effects (acne, hair changes) are rare and reversible.
In India, off-label testosterone prescriptions for women are legally available but require a knowledgeable gynecologist or endocrinologist. Getting tested (serum free testosterone) before starting is important — treatment without confirmed deficiency is not indicated.
The Oral Contraceptive Pill and Libido: A Complicated Relationship
This is one of the most important conversations that many women never have with their doctors. Combined oral contraceptive pills (OCPs) work by suppressing ovulation — but they also increase Sex Hormone Binding Globulin (SHBG), a protein that binds to free testosterone in the blood and makes it unavailable to tissues. The result? Even if total testosterone is normal, free testosterone can be significantly reduced.
Studies show that about 15-30% of women on combined OCPs experience reduced libido. The SHBG elevation can persist for 6-12 months after stopping the pill — explaining why some women notice persistent low desire even after discontinuing contraception.
If you’re on the pill and experiencing low libido, this may be the conversation to have with your gynecologist. Progestin-only pills (the “mini-pill”) or non-hormonal options (IUD, condoms) may be worth discussing — every woman’s hormonal response to contraception is different.
When It’s the Mind, Not the Body: Psychological Drivers
Psychological factors account for approximately 40% of low libido cases — making it the single largest category. The brain is the primary sex organ; without mental arousal, physical arousal rarely follows for women.
- Depression: Both the condition itself (through neurotransmitter changes) and the treatments (SSRIs) suppress sexual desire. If you’re on antidepressants and experiencing low libido, ask your psychiatrist about switching to Bupropion (Wellbutrin) — an antidepressant that often improves libido rather than suppressing it.
- Body image and sexual self-schema: Women who have negative views of their bodies report significantly lower sexual desire and arousal. This isn’t vanity — it’s neuroscience. Self-consciousness during sex activates the brain’s threat response, which directly competes with the arousal response.
- History of trauma or sexual abuse: Approximately 30% of women with HSDD have a history of sexual trauma. This requires specialized trauma-informed therapy — CBT alone is insufficient. EMDR (Eye Movement Desensitization and Reprocessing) has emerging evidence for sexual trauma treatment.
- Relationship context: Women’s libido is highly context-dependent. Research by Emily Nagoski (Come As You Are) conceptualizes this as a “dual control model” — with accelerators (what turns you on) and brakes (what turns you off). For many women, emotional safety and feeling desired by their partner are prerequisites, not bonuses.
Menopause and Perimenopause: What to Expect and What to Do
The hormonal changes of perimenopause and menopause are among the most significant biological drivers of low libido. Estrogen falls dramatically, causing the Genitourinary Syndrome of Menopause (GSM) — vaginal dryness, thinning of vaginal tissue, reduced clitoral sensitivity, and painful intercourse. When sex hurts, desire logically diminishes.
Effective options for menopausal women include:
- Local vaginal estrogen (Vagifem, Estring): Highly effective for GSM. Minimal systemic absorption — generally safe even for women who cannot use systemic HRT. Significantly improves vaginal comfort and indirectly increases desire.
- Systemic HRT: When hot flashes, sleep disruption, and general menopause symptoms are also present, systemic estrogen (with or without progesterone) addresses the full picture. Modern evidence suggests benefits outweigh risks for most women under 60 in the first 10 years post-menopause.
- Ospemifene (Senshio): A SERM that improves vaginal tissue without estrogen — an option for women with estrogen-sensitive breast cancer history.
- Low-dose testosterone: As mentioned, postmenopausal women are the group with the strongest evidence for testosterone therapy in HSDD.
Flibanserin (Addyi): The Only FDA-Approved HSDD Drug for Women
Flibanserin (brand name Addyi) was approved by the FDA in 2015 specifically for premenopausal women with HSDD. It works differently from how many people expect — it’s not a “female Viagra.” Flibanserin is a daily pill that modulates brain neurotransmitters (increasing dopamine and norepinephrine, decreasing serotonin) to restore spontaneous sexual desire over time.
Clinical trials showed approximately 0.5–1 additional “satisfying sexual events” per month compared to placebo — a modest effect size. Side effects include dizziness, somnolence, and a significant interaction with alcohol (contraindicated). It’s currently available in India on import basis.
Bremelanotide (Vyleesi), an injectable option approved in 2019, is another alternative that works through melanocortin receptors — taken as needed rather than daily.
What Actually Works: The Diagnostic First Step
The most important — and most underutilized — approach is finding out why libido is low before treating it. A proper workup should include:
- Hormonal panel: Free testosterone, SHBG, estradiol, FSH, LH, TSH, Prolactin
- Medication review: SSRIs, OCPs, antihypertensives, antipsychotics all implicated
- Mental health screen: PHQ-9 (depression), GAD-7 (anxiety)
- Relationship and sexual history: Responsive vs spontaneous desire pattern, history of trauma
Without this foundation, treatment becomes guesswork. A gynecologist, endocrinologist, or sexual medicine specialist is the right starting point — ideally one comfortable discussing these topics without dismissing them as “just stress.”
Key Takeaways
- Low libido affects 43% of women — it’s common, complex, and treatable
- Root causes span hormonal (35%), psychological (40%), relationship (25%), and medication factors
- Testosterone plays a documented role in female libido — and low-dose therapy has strong RCT evidence
- Oral contraceptive pills raise SHBG and can reduce free testosterone — worth investigating if symptomatic
- SSRIs cause libido suppression in 30% of users — Bupropion is often a better-tolerated alternative
- Menopause-related GSM is highly treatable with local vaginal estrogen
- Diagnosis before treatment — get a hormonal workup first
Low libido is not “just how you are.” It’s not inevitable. And it’s certainly not something you should accept in silence. Ask your doctor — and if they dismiss you, find one who won’t.
Frequently Asked Questions
Is low libido in women always hormonal?
No. Psychological factors (depression, anxiety, body image, trauma) account for about 40% of cases — the largest single category. Relationship dynamics and medications are also major contributors. Hormonal causes (testosterone, estrogen, thyroid) account for approximately 35%.
Can the birth control pill cause low libido?
Yes, in 15-30% of women. Combined OCPs increase SHBG, which binds free testosterone and makes it biologically unavailable. The effect can persist months after stopping. Progestin-only or non-hormonal contraception may be worth discussing with your doctor.
Does testosterone therapy cause masculinization in women?
At the low doses used for HSDD treatment, masculinizing side effects are rare and reversible. Proper monitoring with lab values keeps doses within the female physiological range. A knowledgeable endocrinologist or sexual medicine specialist should oversee this.
Is HSDD a real medical condition or just a label?
It is a recognized DSM-5 diagnosis. The key diagnostic criterion is personal distress — low desire that bothers you. It has documented neurobiological correlates, responds to specific medical and psychological treatments, and is taken seriously by professional medical bodies including ISSWSH and the Endocrine Society.
What is the fastest way to improve female libido?
Address the root cause — this is the most effective intervention. If it’s medication-induced, switching drugs (e.g., Bupropion for SSRIs) can show results within weeks. If hormonal, testosterone therapy typically shows improvement in 4-8 weeks. Mindfulness-based sex therapy and CBT typically show measurable improvement within 8-12 weeks.
Low libido in women is highly treatable with the right approach. Hormone therapy, testosterone supplementation, and HSDD medications like flibanserin are proven medical options for low libido in women. Lifestyle changes — reducing stress, improving sleep, and regular exercise — also significantly improve low libido in women naturally. Sex therapy and couples counselling address the relationship and psychological dimensions of low libido in women. Most women see meaningful improvement with the right combination of medical and lifestyle interventions.
The hormonal roots of low libido in women are well-documented. Oestrogen and testosterone both decline after menopause, directly contributing to low libido in women over 50. Thyroid disorders are another underdiagnosed driver of low libido in women — both hypothyroidism and hyperthyroidism reduce sexual desire. Low libido in women during pregnancy and postpartum is triggered by prolactin, oxytocin, and fatigue from caregiving. Antidepressants — particularly SSRIs — are a leading medication-related cause of low libido in women. Hormonal contraceptives can also suppress testosterone, causing low libido in women who were previously satisfied. Treating the hormonal root cause is the most effective pathway to resolving low libido in women long-term.
Psychological factors in low libido in women deserve equal attention. Anxiety, depression, and past trauma all contribute significantly to low libido in women. Couples therapy and sex therapy are highly effective for low libido in women driven by relationship stress or communication breakdown. Mindfulness-based interventions for low libido in women have shown strong results in clinical trials, improving desire and satisfaction. Exercise, sleep, and nutrition all meaningfully support resolution of low libido in women.
For evidence-based resources on low libido in women, see the International Society for the Study of Women’s Sexual Health (ISSWSH) and the American College of Obstetricians and Gynecologists. The NHS guide on loss of libido also provides practical clinical information.